DMB-025
- Generic Name
- DMB-025
Phase 1/2a Study of MPB-1734 in Patients With Advanced Solid Tumors
- First Posted Date
- 2020-11-25
- Last Posted Date
- 2022-05-03
- Lead Sponsor
- MegaPro Biomedical Co. Ltd.
- Target Recruit Count
- 81
- Registration Number
- NCT04643418
- Locations
- 🇨🇳
Taipei Veterans General Hospital, Taipei, Taiwan
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2025. All Rights Reserved by MedPath